Table 3.

Chemotherapy alteration (n =160) using multivariate logistic regression.

	OR (95% CI)	p Value
Age at diagnosis (for increase of 10 year)	1.4 (1.1, 2.0)	.0147
IPI score (ref: 1 or 2)		.1912
≥3	1.9 (0.9, 4.2)
Unknown	2.1 (0.6, 7.2)
Type of chemotherapy received (ref: R-CHOP)		.0555
R-EPOCH	2.1 (1.0, 4.3)
History of hypertension prior to therapy (ref: no)		.3935
Yes	0.7 (0.3, 1.6)
History of hyperlipidemia prior to therapy (ref: no)		.4620
Yes	1.3 (0.6, 2.9)
Hyperglycemic during treatment (ref: no)		.0285
Yes	2.2 (1.1, 4.6)

OR: odds ratio; CI: confidence interval; IPI: International Prognostic Index; R-CHOP: rituximab, cyclophosphamide, doxorubicin, prednisone; R-EPOCH: rituximab, etoposide, cyclophosphamide, doxorubicin, prednisone; ref: reference; n: number of patients.